The Pennsylvania Department of Drug and Alcohol Programs (DDAP) received a $15,129,362 federal Block Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program. The funding will support a comprehensive set of substance abuse prevention, treatment, and recovery services for Pennsylvania residents over the 2-year award period from October 1, 2024 to September 30, 2026. Key...
The Delaware Division of Substance Abuse and Mental Health (DSAMH) received a $155,235,736 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). This 3-year grant aims to enhance and develop Delaware's opioid and stimulant use disorder (OUD/STUD) system of care, with a focus on serving 5 key populations: pregnant/parenting individuals, racial/ethnic minorities,...
This federal Project Grant award for $312,883,599.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) will support the Florida Department of Children and Families in implementing a comprehensive approach to addressing opioid and stimulant misuse, disorders, and overdoses in Florida. The project aims to reduce opioid-caused deaths by increasing access to medication-assisted treatment and...
The Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) received a $94,080,870 Project Grant award under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) from the Substance Abuse and Mental Health Services Administration (SAMHSA). This three-year grant, running from September 30, 2024 to September 29, 2027, aims to enhance the state's prevention, harm reduction, treatment, and recovery activities in response to the opioid epidemic. Key products and...
This $119,563,560 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) will support the New Hampshire Department of Health & Human Services (NH DHHS) in increasing access to substance use disorder services statewide. The grant will fund a comprehensive approach to address the opioid and stimulant use crisis in New Hampshire, including expanding access to...
This Project Grant award for $104,400,264 was made by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) Grant Program (CFDA 93.788). The goal is to reduce the prevalence of opioid and stimulant-related overdose and mortality throughout Arizona. The Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, will use the funding to increase access to medication-assisted treatment for opioid use...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $183,098,460 Project Grant under the Opioid State Targeted Response (Opioid STR) Program (CFDA 93.788) to the West Virginia Department of Human Services (WVDHS) for the West Virginia State Opioid Response (SOR) Grant. This grant will fund the expansion of evidence-based prevention, early intervention, treatment, and recovery management activities for opioid use disorder (OUD)...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $21,974,608 Project Grant under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) to the Vermont Agency of Human Services Division of Substance Use Programs to address the opioid crisis in Vermont. This funding will support a comprehensive strategy to increase access to medication-assisted treatment for opioid use disorder, as well as implementation of prevention, harm reduction, treatment, and...
This $71,160,580 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) supports the Wisconsin State Opioid Response (SOR) to address the opioid and stimulant use crisis. The funding will expand access to evidence-based treatment and recovery services, advance prevention and harm reduction efforts, and reduce opioid/stimulant-related overdose deaths, with a focus on...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $111,660,942 Project Grant under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) to the Health Services Kentucky Cabinet For. This 3-year grant will support the implementation of the Kentucky Overdose Response Effort (KORE), a comprehensive strategy to address the opioid and stimulant crisis in Kentucky. Key activities include: Expanding access to...
The Pennsylvania Department of Drug and Alcohol Programs (DDAP) received a $249,455,328 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) Grant Program (CFDA 93.788). The award, effective September 30, 2024 through September 29, 2027, will support a comprehensive statewide strategy to address the opioid and stimulant use crisis in Pennsylvania. Key initiatives include: expanding access to medication-assisted treatment and naloxone distribution; enhancing prevention, harm reduction, treatment, and recovery support services; and increasing public awareness and stigma reduction efforts. The grant aims to serve over 629,000 individuals, including the uninsured/underinsured, justice-involved populations, veterans, parents, and children. Strategies involve collaborating with multiple state agencies and organizations to implement evidence-based interventions and achieve the state's substance abuse prevention and treatment goals.